Related Experiment Video
Updated: May 23, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Adherence and dosing frequency of common medications for cardiovascular patients
Jay P Bae1, Paul P Dobesh, Donald G Klepser
1College of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, NE 68198-6045, USA.
Insights
Once-daily (QD) dosing significantly improved medication adherence compared to twice-daily (BID) dosing for chronic cardiovascular disease medications. This finding highlights the importance of dosing frequency for patient adherence and treatment effectiveness.
Area of Science:
- Pharmacology and Pharmaceutics
- Cardiovascular Medicine
- Health Services Research
Background:
- Medication adherence is crucial for managing chronic cardiovascular diseases.
- Dosing frequency (once-daily vs. twice-daily) can significantly impact patient adherence.
- Understanding adherence patterns for different dosing regimens is essential for optimizing patient outcomes.
Purpose of the Study:
- To compare medication adherence between once-daily (QD) and twice-daily (BID) dosing regimens.
- To evaluate adherence for chronic-use prescription medications in patients with cardiovascular disease.
- To identify potential differences in adherence based on therapeutic class and dosing frequency.
Main Methods:
- Retrospective cohort database analysis of 1,077,474 patients aged over 18 years.
- Included patients with prescriptions for antidiabetic, antihyperlipidemic, antiplatelet, or cardiac agents between January 1 and December 31, 2007.
- Adherence measured by medication possession ratio (MPR); analyzed using generalized estimating equations, controlling for covariates.
Main Results:
- Overall adjusted mean MPR was 13.6% higher for QD dosing compared to BID dosing (0.66 vs. 0.57, P < .01).
- QD dosing showed significantly greater adherence in antidiabetic (2.9%), antihyperlipidemic (17.5%), and antiplatelet (29.4%) classes.
- Cardiac agents showed similar adherence between QD and BID, with QD carvedilol slightly outperforming BID carvedilol (11% difference, P < .01).
Conclusions:
- Once-daily (QD) dosing regimens are associated with significantly greater medication adherence compared to twice-daily (BID) regimens.
- The findings suggest that simplifying dosing schedules can improve patient adherence in chronic disease management.
- Further research may explore patient-specific factors influencing adherence across different dosing frequencies.
Objectives:
To compare adherence between once-daily (QD) and twice-daily (BID) dosing with chronic-use prescription medications used by patients with cardiovascular disease.
Study Design:
Retrospective cohort database analysis.
Methods:
Analysis consisted of 1,077,474 patients aged >18 years with a prescription index date from January 1 to December 31, 2007, for an antidiabetic, antihyperlipidemic, antiplatelet, or cardiac agent with QD or BID dosing. Adherence (medication possession ratio [MPR]) was the number of days of medication supplied between the first prescription fill date and the subsequent 365 days divided by 365 days. Overall mean MPR and comparisons between dosing frequency groups were assessed with a generalized estimating equation. Covariates included age at index date, gender, Charlson comorbidity index, therapeutic class, dosing frequency, and the interaction between therapeutic class and dosing frequency group.
Results:
Overall, the adjusted mean MPR ± standard error (SE) value for QD agents was 13.6% greater than BID agents (0.66 ± 0.0006 vs 0.57 ± 0.0016; P <.01). The adjusted mean MPR value for QD agents was 2.9%, 17.5%, and 29.4% greater than BID agents in the antidiabetic, antihyperlipidemic, and antiplatelet therapeutic classes, respectively. For cardiac agents, the adjusted mean MPR value was similar between QD and BID agents. Carvedilol represented approximately 80% of the cardiac agents in the BID group. The adjusted mean MPR ± SE for carvedilol phosphate QD was 0.73 ± 0.0024 and 0.65 ± 0.0027 for carvedilol BID (11% difference; P <.01).
Conclusions:
In this large analysis, the QD dosing regimen was related to greater adherence versus a BID regimen.
Related Concept Videos
Dose Size and Dosing Frequency: Determination Methods
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Dosage Regimens: Designs and Approaches
Dysrhythmias VII: Nursing Management of Dysrhythmias